214 related articles for article (PubMed ID: 1686527)
1. Histamine(H1) antagonists and airway hyperreactivity in the guinea-pig.
Hoshiko K; Chapman ID; Morley J
Agents Actions Suppl; 1991; 34():323-33. PubMed ID: 1686527
[TBL] [Abstract][Full Text] [Related]
2. Changes in airway sensitivity to histamine are not necessarily paralleled by changed sensitivity to acetylcholine.
Mazzoni L; Chapman ID; Morley J
Agents Actions Suppl; 1991; 34():257-66. PubMed ID: 1793069
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of epinastine on bronchoconstriction induced by histamine, platelet activating factor and serotonin in guinea pigs and rats.
Tasaka K; Kamei C; Nakamura S
Arzneimittelforschung; 1994 Mar; 44(3):327-9. PubMed ID: 7910745
[TBL] [Abstract][Full Text] [Related]
4. Effects of histamine H1 receptor antagonists on action potentials in guinea-pig isolated papillary muscles.
Ki I; Inui A; Ito T
Arch Int Pharmacodyn Ther; 1996; 331(1):59-73. PubMed ID: 8896711
[TBL] [Abstract][Full Text] [Related]
5. Antiasthma activity of the novel antihistamine E-4716 in guinea pigs in vivo.
Cortijo J; Farré AJ; Gutierrez B; Morcillo EJ
Methods Find Exp Clin Pharmacol; 1996 Sep; 18(7):465-73. PubMed ID: 8900220
[TBL] [Abstract][Full Text] [Related]
6. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects.
Kamei C; Mio M; Kitazumi K; Tsujimoto S; Yoshida T; Adachi Y; Tasaka K
Immunopharmacol Immunotoxicol; 1992; 14(1-2):207-18. PubMed ID: 1350791
[TBL] [Abstract][Full Text] [Related]
7. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
Sansom JE; Brooks J; Burton JL; Archer CB
Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
[TBL] [Abstract][Full Text] [Related]
8. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
9. [Azelastine inhibits bronchoconstriction induced by histamine and leukotriene C4].
Tomooka M; Miyazaki N; Aizawa H; Shigematsu N; Ejima T
Arerugi; 1988 Apr; 37(4):213-7. PubMed ID: 2906534
[No Abstract] [Full Text] [Related]
10. The effect of the selective PAF antagonist CIS-19 on PAF- and antigen-induced bronchoconstriction, microvascular leakage and bronchial hyperreactivity in guinea-pigs.
Lin CH; Ko FN; Ishii H; Ishikawa T; Chen IS; Teng CM; Kuo HP
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):210-6. PubMed ID: 9050014
[TBL] [Abstract][Full Text] [Related]
11. Effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimida zole difumarate (KB-2413), a new antiallergic, on chemical mediators.
Fukuda T; Morimoto Y; Iemura R; Kawashima T; Tsukamoto G; Ito K
Arzneimittelforschung; 1984; 34(7):801-5. PubMed ID: 6149754
[TBL] [Abstract][Full Text] [Related]
12. Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models.
Llupià J; Gras J; Llenas J
Arzneimittelforschung; 2003; 53(2):93-7. PubMed ID: 12642964
[TBL] [Abstract][Full Text] [Related]
13. [Bronchial hyperresponsiveness to histamine in guinea pig induced by intravenous administration of platelet activating factor].
Tsukagoshi H; Aoki S; Kurosawa M
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Nov; 28(11):1450-5. PubMed ID: 2290229
[TBL] [Abstract][Full Text] [Related]
14. [Effect of Asthremedin on bronchial hyperresponsiveness (BHR) to histamine induced by intravenous administration of platelet activating factor (PAF) in guinea pigs].
Tsukagoshi H; Kurosawa M
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Mar; 31(3):310-6. PubMed ID: 8391092
[TBL] [Abstract][Full Text] [Related]
15. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
Fügner A; Bechtel WD; Kuhn FJ; Mierau J
Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.
Van Neste D; Rihoux JP
Skin Pharmacol; 1988; 1(3):192-9. PubMed ID: 2908486
[TBL] [Abstract][Full Text] [Related]
18. Effect of NZ-107 on late-phase airway responses and airway hyperreactivity in guinea pigs.
Iwama T; Shikada K; Yamamoto A; Sakashita M; Hibi M; Tanaka S
Eur J Pharmacol; 1991 Jul; 199(3):271-8. PubMed ID: 1915580
[TBL] [Abstract][Full Text] [Related]
19. The effect of prophylactic anti-asthma drugs on PAF-induced airway hyperreactivity.
Sanjar S; Smith D; Schaeublin E; Kristersson A; Chapman I; Mazzoni L; Morley J
Jpn J Pharmacol; 1989 Oct; 51(2):151-60. PubMed ID: 2574244
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
